Company

Cellbricks Therapeutics

Biotechnology Bayer, Ag, De 28 employees

Employees: 28
Contacts: 1
Emails: 1
Phones: 1

cellbricks.com LinkedIn

Cellbricks Therapeutics Overview

Headquarters: Bayer, Ag, De
Website: cellbricks.com
Industry: Biotechnology
Employees: 28
Founded: 2016

Keywords

3D Bioprinting Bioink Biotechnology Tissue engineering Breast cancer Regenerative medicine LabModels Recombinant Collagen TechBio Oncology Pharma Lifesciences

About Cellbricks Therapeutics

Cellbricks Therapeutics is a Berlin-based biotech company pioneering the future of regenerative medicine and longevity. Built on deeptech innovation, the company combines proprietary 3D- bioprinting technology with advanced biomaterials and human cells to develop implantable tissue grafts for clinical use. Cellbricks’ mission is to transform healthcare by restoring organ function and replacing damaged tissue with living, functional implants – produced reliably and at scale. For inquiries please contact: mm@cellbricks.com

Cellbricks Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage
Phone contacts: 1; 25.0% coverage

Cellbricks Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Zeynab Mirzaei, Ph.d.	Senior Tissue Engineer at Cellbricks Gmbh	Berlin, Germany	View
Markus Wild	I Invest in People with Attitude, Business Ideas with Substance and Brands That Leverage Design Strategically.	Ruhr Region, Germany	Email Phone
Okan Kara, Phd	Engineer by Training. Innovation at Heart. Investor by Mission.		View
Simon Mackenzie	Chief Executive Officer - Leading Tissue Therapeutics Programs		View